CENTER VALLEY, Pa., Sept. 20, 2021 /PRNewswire/ — Olympus has been selected to exhibit the iTind TM device, a temporarily implanted device for relief of enlarged prostate symptoms, at the Vizient ...

FDA has granted de novo classification to a non-surgical device for the minimally invasive treatment of Benign Prostatic Hyperplasia (BPH). The iTind device was developed by Or Akiva, Israel-based ...

CENTER VALLEY, Pa. , Oct. 20, 2023 /PRNewswire/ -- Olympus Corporation, a global medical technology company committed to making people's lives healthier, safer, and more fulfilling, announced today ...

CENTER VALLEY, Pa., July 13, 2023 /PRNewswire/ -- Olympus Corporation, a global medical technology company, announced publication of study data demonstrating that the minimally invasive iTind™ ...

CENTER VALLEY, Pa., Sept. 7, 2021 /PRNewswire/ — Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, will highlight its expanded ...

Olympus honored with both the 2022 Medical Design Excellence Award and 2022 Edison Award CENTER VALLEY, Pa., May 13, 2022 /PRNewswire/ -- Olympus, a global technology leader in designing and ...

～Initiate Discussion for Acquisition to expand Minimally Invasive Treatment product portfolio～ TOKYO & HAMBURG, Germany--(BUSINESS WIRE)--Olympus Corporation (”Olympus” – Director, Representative ...

TOKYO & HAMBURG, Germany & CENTER VALLEY, Pa.--(BUSINESS WIRE)--Olympus Corporation (”Olympus” – Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) announced today that it ...